Table 2 Treatment characteristics of the study cohort
From: Prostate cancer presentation and management in the Middle East
Treatment for non-metastatic patients, No. (%) | |
No treatment | 106 (20) |
Radical prostatectomy alone | 84 (16) |
Radiotherapy alone | 28 (5) |
ADT alone | 45 (8) |
Radical prostatectomy + radiotherapy + ADT | 30 (6) |
Radical prostatectomy + ADT | 10 (2) |
Radiotherapy + ADT | 228 (43) |
Treatment for metastatic patients, No. (%) | |
No treatment | 132 (22) |
ADT +/- additional systemic therapy | 343 (56) |
Palliative radiotherapy to metastases | 140 (22) |